Nature Communications (Sep 2023)

Germinal center output is sustained by HELLS-dependent DNA-methylation-maintenance in B cells

  • Clara Cousu,
  • Eléonore Mulot,
  • Annie De Smet,
  • Sara Formichetti,
  • Damiana Lecoeuche,
  • Jianke Ren,
  • Kathrin Muegge,
  • Matthieu Boulard,
  • Jean-Claude Weill,
  • Claude-Agnès Reynaud,
  • Sébastien Storck

DOI
https://doi.org/10.1038/s41467-023-41317-3
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 21

Abstract

Read online

Abstract HELLS/LSH (Helicase, Lymphoid Specific) is a SNF2-like chromatin remodelling protein involved in DNA methylation. Its loss-of-function in humans causes humoral immunodeficiency, called ICF4 syndrome (Immunodeficiency, Centromeric Instability, Facial anomalies). Here we show by our newly generated B-cell-specific Hells conditional knockout mouse model that HELLS plays a pivotal role in T-dependent B-cell responses. HELLS deficiency induces accelerated decay of germinal center (GC) B cells and impairs the generation of high affinity memory B cells and circulating antibodies. Mutant GC B cells undergo dramatic DNA hypomethylation and massive de-repression of evolutionary recent retrotransposons, which surprisingly does not directly affect their survival. Instead, they prematurely upregulate either memory B cell markers or the transcription factor ATF4, which is driving an mTORC1-dependent metabolic program typical of plasma cells. Treatment of wild type mice with a DNMT1-specific inhibitor phenocopies the accelerated kinetics, thus pointing towards DNA-methylation maintenance by HELLS being a crucial mechanism to fine-tune the GC transcriptional program and enable long-lasting humoral immunity.